Bio-Rad Laboratories (BIO) | Stock Overview & Key Data
Bio-Rad Laboratories Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $832.70 on August 30, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.60B Mid-cap | -0.70% | 16.87% | 10.73% | -6.05% | -5.24% | 26.01% | -24.07% | -54.09% | 102.91% | 143.91% | 328.31% | |
| 160.70B Large-cap | -2.02% | 4.97% | -19.35% | -30.98% | -28.60% | -34.98% | -16.97% | -20.08% | 135.84% | 255.56% | 329.52% | |
|
Stryker
SYK
|
126.25B Large-cap | 2.13% | 0.38% | -11.91% | -13.33% | -11.56% | -17.25% | 6.06% | 22.47% | 172.95% | 440.98% | 592.85% |
|
Masimo
MASI
|
9.36B Mid-cap | 0.63% | 0.78% | 2.54% | 30.08% | 41.25% | 11.63% | 11.44% | -25.04% | 256.34% | 498.24% | 798.85% |
|
Bio-Rad
BIO.B
|
8.08B Mid-cap | 0.00% | 19.02% | 13.26% | -2.11% | -2.11% | 21.62% | -18.04% | -47.52% | 116.35% | 158.70% | 354.57% |
|
Glaukos
GKOS
|
7.07B Mid-cap | 6.71% | -9.63% | 31.53% | 16.48% | 17.54% | 29.93% | 87.26% | 54.84% | 339.09% | 352.89% | 352.89% |
Ownership & Short Interest
Calculate Your Bio-Rad Laboratories Investment Returns
Long-Term Investment Performance Analysis
Bio-Rad Laboratories stock price in Jul 2016 was $142.99, A $1,000.00 lump sum investment in Bio-Rad Laboratories made 9 years ago would be worth approximately $2,023.08 today, representing a strong return of 102.31%. This translates to an annualized return (CAGR) of 7.37%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is BIO's 52-week high and low?
- In the last 52 weeks, Bio-Rad Laboratories reached a high of $343.12 (on October 27, 2025) and a low of $222.80 (on June 16, 2025).
- What is the market cap and P/E ratio for BIO?
- Curious about Bio-Rad Laboratories's size and valuation? Its market capitalization stands at 7.60B. When it comes to valuation, the P/E ratio (trailing twelve months) is 10.98, and the forward P/E (looking ahead) is 26.94.
- Does BIO pay dividends? If so, what's the yield?
- As for dividends, Bio-Rad Laboratories isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Bio-Rad Laboratories's main competitors or similar companies to consider before investing?
When looking at Bio-Rad Laboratories, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT160.70B Healthcare Medical Devices -34.98% -16.97% Stryker
SYK126.25B Healthcare Medical Devices -17.25% 6.06% Masimo
MASI9.36B Healthcare Medical Devices 11.63% 11.44% Bio-Rad
BIO.B8.08B Healthcare Medical Devices 21.62% -18.04% Glaukos
GKOS7.07B Healthcare Medical Devices 29.93% 87.26% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Bio-Rad Laboratories Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Bio-Rad Laboratories's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 10.84%, the Debt to Equity ratio from the most recent quarter is 18.58, and its Gross Profit Margin stands at 49.80%.
- What is the recent revenue and earnings growth for BIO?
- Looking at Bio-Rad Laboratories's growth, its revenue over the trailing twelve months (TTM) was $3B. Compared to the same quarter last year (YoY), quarterly revenue grew by 3.90%, and quarterly earnings saw a YoY growth of 3.85%.
- How much of BIO stock is held by insiders and institutions?
- Wondering who owns Bio-Rad Laboratories stock? Company insiders (like executives and directors) hold about 16.20% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 91.50%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.